<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04220567</url>
  </required_header>
  <id_info>
    <org_study_id>IPSetubalESS_SHARE</org_study_id>
    <nct_id>NCT04220567</nct_id>
  </id_info>
  <brief_title>Effectiveness of Exercise and Patient-centred Education on Fibromyalgia</brief_title>
  <official_title>Is a Combined Programme of Exercise and Patient-centred Education More Effective Than Exercise Alone in Individuals With Fibromyalgia? A Randomised Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto Politécnico de Setúbal. Escola Superior de Saúde.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Universidade de Lisboa - Faculdade Letras</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centro Hospitalar de Setúbal E.P.E.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centro Hospitalar Lisboa Ocidental</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Myos - Associação Nacional Contra a Fibromialgia e Síndrome de Fadiga Crónica</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Instituto Politécnico de Setúbal. Escola Superior de Saúde.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to compare the effects of an eight-week exercise and patient-centred
      education programme with eight-week exercise alone programme on disability, pain intensity,
      health-related quality of life and patient global impression of change.

      A prospective, parallel, double-blinded and multi-centre randomised controlled trial will be
      carried out.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 7, 2020</start_date>
  <completion_date type="Anticipated">October 2020</completion_date>
  <primary_completion_date type="Anticipated">October 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Parallel assignment</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>Double blind</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Pain intensity</measure>
    <time_frame>Baseline</time_frame>
    <description>Measured using the Numeric Pain Rating Scale, NPS, 0-10</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain intensity</measure>
    <time_frame>4 weeks</time_frame>
    <description>Measured using the Numeric Pain Rating Scale, NPS, 0-10</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain intensity</measure>
    <time_frame>8 weeks</time_frame>
    <description>Measured using the Numeric Pain Rating Scale, NPS, 0-10</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain intensity</measure>
    <time_frame>Follow-up 3 months</time_frame>
    <description>Measured using the Numeric Pain Rating Scale, NPS, 0-10</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Disability and Impact of Fibromyalgia</measure>
    <time_frame>Baseline</time_frame>
    <description>Measured using the Revised Fibromyalgia Impact Questionnaire, FIQr, 0-100</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Disability and Impact of Fibromyalgia</measure>
    <time_frame>4 weeks</time_frame>
    <description>Measured using the Revised Fibromyalgia Impact Questionnaire, FIQr, 0-100</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Disability and Impact of Fibromyalgia</measure>
    <time_frame>8 weeks</time_frame>
    <description>Measured using the Revised Fibromyalgia Impact Questionnaire, FIQr, 0-100</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Disability and Impact of Fibromyalgia</measure>
    <time_frame>Follow-up 3 months</time_frame>
    <description>Measured using the Revised Fibromyalgia Impact Questionnaire, FIQr, 0-100</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Neuropathic components in pain</measure>
    <time_frame>Baseline</time_frame>
    <description>Measured using the painDETECT Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health-related Quality of Life</measure>
    <time_frame>Baseline</time_frame>
    <description>Measured using the EuroQol 5D 3L, EQ 5D-3L</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health-related Quality of Life</measure>
    <time_frame>4 weeks</time_frame>
    <description>Measured using the EuroQol 5D 3L, EQ 5D-3L</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health-related Quality of Life</measure>
    <time_frame>8 weeks</time_frame>
    <description>Measured using the EuroQol 5D 3L, EQ 5D-3L</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health-related Quality of Life</measure>
    <time_frame>Follow-up 3 months</time_frame>
    <description>Measured using the EuroQol 5D 3L, EQ 5D-3L</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patients` perception of improvement or decline in clinical status</measure>
    <time_frame>4 weeks</time_frame>
    <description>Measured using the The Patient Global Impression of Change Scale, PGIC, 1-7</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patients` perception of improvement or decline in clinical status</measure>
    <time_frame>8 weeks</time_frame>
    <description>Measured using the Patient Global Impression of Change Scale, PGIC, 1-7</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patients` perception of improvement or decline in clinical status</measure>
    <time_frame>Follow-up 3 months</time_frame>
    <description>Measured using the Patient Global Impression of Change Scale, PGIC, 1-7</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Fibromyalgia</condition>
  <arm_group>
    <arm_group_label>Exercise and Patient-centred education</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Exercise</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Experimental: Exercise and Patient-centred education</intervention_name>
    <description>An eight-week programme based on 24 sessions of exercise supervised by a physiotherapist. Exercise will be carried out three times a week. Once a week the exercise session is performed autonomously by patient at home (according to the physiotherapist`s recommendations).
Patient-centred Education will follow the principles of transformative learning &amp; incorporate patients` narratives. It will precede 9 of the 24 exercise sessions and be delivered by the same physiotherapist</description>
    <arm_group_label>Exercise and Patient-centred education</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Active Comparator: Exercise</intervention_name>
    <description>An eight-week programme based on 24 sessions of exercise supervised by a physiotherapist. Exercise will be carried out three times a week. Once a week the exercise session is performed autonomously by patient at home (according to the physiotherapist`s recommendations).</description>
    <arm_group_label>Exercise</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of fibromyalgia according to the American College of Rheumatology criteria
             (2016)

        Exclusion Criteria:

          -  Presence of uncontrolled medical disorders (cardiovascular/ metabolic/ neurological/
             renal)

          -  Presence of active oncological disease (or until 5 years and undergoing treatment)

          -  Presence of inflammatory rheumatic diseases other than fibromyalgia

          -  Presence of inflammatory osteoarticular disease or severe osteoarthritis (grade IV de
             Kellgren - Lawrence Classification of Osteoarthritis)

          -  Previous orthopaedic (column or lower limb) or cardiothoracic surgery in the year
             before;

          -  Disability not compatible with the exercise practice required

          -  Pregnancy

          -  Attendance to a physiotherapy programme including exercise in the previous three
             months

          -  Difficulty in written communication that prevent the fulfilment of self-reported
             questionnaires.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Carmen Caeiro</name>
      <address>
        <city>Setúbal</city>
        <zip>2914-503</zip>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carmen Caeiro, PhD</last_name>
      <phone>00351 265 709 382</phone>
      <phone_ext>5382</phone_ext>
      <email>carmen.caeiro@ess.ips.pt</email>
    </contact>
    <contact_backup>
      <last_name>Patrícia Falcão, BSc Hons</last_name>
      <phone>00351 265 709 382</phone>
      <phone_ext>5382</phone_ext>
      <email>patricia.falcao@ess.ips.pt</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Portugal</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>January 5, 2020</study_first_submitted>
  <study_first_submitted_qc>January 6, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 7, 2020</study_first_posted>
  <last_update_submitted>March 6, 2020</last_update_submitted>
  <last_update_submitted_qc>March 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Fibromyalgia</keyword>
  <keyword>Exercise</keyword>
  <keyword>Patient-centred Education</keyword>
  <keyword>Randomised Controlled Trial</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibromyalgia</mesh_term>
    <mesh_term>Myofascial Pain Syndromes</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

